Goldman Unit Buys €2 Billion Drugmaker Synthon From BC Partners

Estimated read time 1 min read


Goldman Sachs Group Inc.’s alternative investment arm has agreed to buy a majority stake in Dutch generic drugmaker Synthon from BC Partners.

Source link

You May Also Like

More From Author

+ There are no comments

Add yours